Nuvectis Pharma Inc (NVCT)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Ronald E. Bentsur
Employees:
8
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ 07024
360-837-7232

Nuvectis Pharma focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

Data derived from most recent annual or quarterly report
Market Cap 107.465 Million Shares Outstanding12.718 Million Avg 30-day Volume 14.115 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value4.6617 Operating Margin0.0 Enterprise Value51.176 Million
Current Ratio5.759 EPS Growth0 Quick Ratio5.457
1 Yr BETA -0.0428 52-week High/Low 20.92 / 3.08 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score13.0447 Free Cash Flow to Firm 0
Earnings Report2022-11-04
View SEC Filings from NVCT instead.

View recent insider trading info

Funds Holding NVCT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVCT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

4.7 Thousand total shares from 5 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BENTSUR RON CHAIRMAN & CEO

  • Officer
  • Director
  • 10% Owner
2,968,314 2022-06-28 14

SHEMESH SHAY CHIEF DEV. & OPS. OFFICER

  • Officer
1,241,435 2022-05-20 6

HOBERMAN KENNETH

  • Director
55,140 2022-05-12 3

KAPLAN MATTHEW L.

  • Director
35,760 2022-05-12 3

PORADOSU ENRIQUE CHIEF SCIENCE & BUSINESS OFF

  • Officer
1,258,319 2022-05-12 4

OLIVIERO JAMES F III

  • Director
15,000 2022-04-01 2

CARSON MICHAEL J. VICE PRESIDENT, FINANCE

  • Officer
27,300 2022-03-18 1

BEN-OR URI INT. PRINCIPAL FINANCIAL OFF.

  • Officer
25,584 2022-02-08 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BENTSUR RON - Director - Officer - > 10% Owner CHAIRMAN & CEO

2022-06-30 08:30:22 -0400 2022-06-29 P 3,700 $11.62 a 2,968,314 direct 7.0536 13.4821 16.0714 3 0.0 1

BENTSUR RON - Director - Officer - > 10% Owner CHAIRMAN & CEO

2022-06-30 08:30:22 -0400 2022-06-28 P 300 $11.82 a 2,964,614 direct 7.0536 13.4821 16.0714 3 0.0 1

BENTSUR RON - Director - Officer - > 10% Owner CHAIRMAN & CEO

2022-06-27 08:31:52 -0400 2022-06-24 P 400 $12.18 a 2,964,314 direct 0.2483 7.6159 -30.0497 7.6159 6 -30.0497 31

BENTSUR RON - Director - Officer - > 10% Owner CHAIRMAN & CEO

2022-06-27 08:31:52 -0400 2022-06-23 P 200 $11.40 a 2,963,914 direct 0.2483 7.6159 -30.0497 7.6159 6 -30.0497 31

BENTSUR RON - Director - Officer - > 10% Owner CHAIRMAN & CEO

2022-06-27 08:31:52 -0400 2022-06-22 P 100 $13.10 a 2,963,714 direct 0.2483 7.6159 -30.0497 7.6159 6 -30.0497 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NUVECTIS PHARMA INC NVCT 2022-08-10 21:45:04 UTC -64.3765 66.6965 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 21:15:05 UTC -64.3765 66.6965 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 20:45:04 UTC -64.3765 66.6965 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 20:15:06 UTC -64.3765 66.6965 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 19:45:04 UTC -64.3765 66.6965 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 19:15:05 UTC -64.3765 66.6965 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 18:45:04 UTC -64.3964 66.7164 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 18:15:04 UTC -64.3964 66.7164 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 17:45:04 UTC -64.3964 66.7164 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 17:15:04 UTC -64.3964 66.7164 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 16:45:04 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 16:15:03 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 15:45:05 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 15:15:05 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 14:45:04 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 14:15:03 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 13:45:03 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 13:15:04 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-10 12:45:05 UTC -64.5571 66.8771 2000
NUVECTIS PHARMA INC NVCT 2022-08-09 22:15:07 UTC -64.5571 66.8771 2000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments